Alterola Biotech, Inc. (ABTI)
 OTCMKTS  · Delayed Price · Currency is USD  
0.2000
 +0.1998 (99,900.00%)
  Oct 31, 2025, 3:00 PM EST
Alterola Biotech Statistics
Total Valuation
ABTI has a market cap or net worth of 296,253. The enterprise value is 2.37 million.
| Market Cap | 296,253 | 
| Enterprise Value | 2.37M | 
Important Dates
The next estimated earnings date is Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
ABTI has 1.48 billion shares outstanding.
| Current Share Class | 1.48B | 
| Shares Outstanding | 1.48B | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | +2.64% | 
| Owned by Insiders (%) | 42.21% | 
| Owned by Institutions (%) | n/a | 
| Float | 382.86M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | -0.13 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -0.85 | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
The company has a current ratio of 0.32
| Current Ratio | 0.32 | 
| Quick Ratio | 0.02 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | -7.56 | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | -171.36% | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | 113.34% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | -2.78M | 
| Employee Count | 1 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has increased by +3,673.59% in the last 52 weeks. The beta is 74.33, so ABTI's price volatility has been higher than the market average.
| Beta (5Y) | 74.33 | 
| 52-Week Price Change | +3,673.59% | 
| 50-Day Moving Average | 0.00 | 
| 200-Day Moving Average | 0.05 | 
| Relative Strength Index (RSI) | 2.77 | 
| Average Volume (20 Days) | n/a | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | 0.00 | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -2.55M | 
| Pretax Income | -2.97M | 
| Net Income | -2.78M | 
| EBITDA | n/a | 
| EBIT | -2.55M | 
| Earnings Per Share (EPS) | -0.00 | 
Balance Sheet
The company has 82,720 in cash and 2.35 million in debt, giving a net cash position of -2.27 million or -0.00 per share.
| Cash & Cash Equivalents | 82,720 | 
| Total Debt | 2.35M | 
| Net Cash | -2.27M | 
| Net Cash Per Share | -0.00 | 
| Equity (Book Value) | -2.25M | 
| Book Value Per Share | -0.00 | 
| Working Capital | -2.47M | 
Cash Flow
| Operating Cash Flow | -2.32M | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
ABTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -70.86% | 
| Shareholder Yield | -70.86% | 
| Earnings Yield | -937.43% | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | 2 |